4 news items
Axonics Receives Regulatory Approval for Recharge-Free SNM System in Australia
AXNX
16 May 24
in Australia," said Raymond W. Cohen, chief executive officer of Axonics. "Our mission-driven team remains committed to innovating, supporting our dedicated
Axonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
AXNX
14 Mar 24
another significant breakthrough for rechargeable neuromodulation devices and underscores Axonics' commitment to continuous innovation. We are confident
Axonics Responds To ITC Action By Medtronic; CEO Says "We Believe Medtronic's Claims Are Designed To Stifle Competition, Limit Patient And Physician Choice, And Protect The Incumbent's Market Position"
AXNX
MDT
29 Feb 24
took advantage of its monopoly position in this category and chose not to innovate, develop full-body MRI compatible sacral neuromodulation devices
Axonics Responds to ITC Action by Medtronic
AXNX
29 Feb 24
not to innovate, develop full-body MRI compatible sacral neuromodulation devices or invest in creating public awareness of advanced therapies for people
- Prev
- 1
- Next